Search

everythinglearnresearchcommunity

for

Search:↓

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Not all cases with typical signs of Alopecia Areata are actually diagnosed as such.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The document's conclusion cannot be provided because the document is not accessible or not in a readable format.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.

People who use minoxidil for hair loss often stop within 3.5 months due to lack of improvement, so educating them early on may help them stick with it.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Immune activities and specific genes are important in male pattern baldness.

IGF-1R may play a role in female hair loss and could be a treatment target.

Trichoscopy helps diagnose female hair loss easily.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Black and Hispanic women are more likely to have alopecia areata than white women.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.